Abaloparatide Is an Anabolic, but Does It Spare Resorption?
- PMID: 27859635
- DOI: 10.1002/jbmr.3042
Abaloparatide Is an Anabolic, but Does It Spare Resorption?
Comment on
-
Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.JAMA. 2016 Aug 16;316(7):722-33. doi: 10.1001/jama.2016.11136. JAMA. 2016. PMID: 27533157 Clinical Trial.
-
Effects of Abaloparatide-SC on Fractures and Bone Mineral Density in Subgroups of Postmenopausal Women With Osteoporosis and Varying Baseline Risk Factors.J Bone Miner Res. 2017 Jan;32(1):17-23. doi: 10.1002/jbmr.2991. Epub 2016 Sep 28. J Bone Miner Res. 2017. PMID: 27612281 Clinical Trial.
-
One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption.J Bone Miner Res. 2017 Jan;32(1):24-33. doi: 10.1002/jbmr.3003. Epub 2016 Oct 17. J Bone Miner Res. 2017. PMID: 27748532
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical